{
    "root": "4a19b4d6-9b86-4b20-befb-6c50a3898df4",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "Human Prescription Drug Label",
    "name": {
        "text": "NICARDIPINE HYDROCHLORIDE"
    },
    "value": "20230623",
    "ingredients": [
        {
            "name": "NICARDIPINE HYDROCHLORIDE",
            "code": "K5BC5011K3"
        },
        {
            "name": "SORBITOL",
            "code": "506T60A25R"
        },
        {
            "name": "CITRIC ACID MONOHYDRATE",
            "code": "2968PHW8QP"
        },
        {
            "name": "SODIUM HYDROXIDE",
            "code": "55X04QC32I"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R"
        }
    ],
    "indications": "Nicardipine hydrochloride injection is a calcium channel blocker indicated for the short-term treatment of hypertension when oral therapy is not feasible. ( 1.1 )",
    "contraindications": "For Intravenous Use. ( 2.1 ) Dilution is required. ( 2.3 ) When substituting for oral nicardipine therapy, use the intravenous infusion rate from the table below ( 2.1 ): Oral Nicardipine Hydrochloride Dose Equivalent Intravenous Infusion Rate (0.1 mg/mL) 20 mg q8h 0.5 mg/hr = 5 mL/hr 30 mg q8h 1.2 mg/hr = 12 mL/hr 40 mg q8h 2.2 mg/hr = 22 mL/hr In a patient not receiving oral nicardipine, initiate therapy at 50 mL/hr (5 mg/hr) 0.1 mg/mL solution. Increase the infusion rate by 25 mL/hr every 5 minutes (for rapid titration) to 15 minutes (for gradual titration) up to a maximum of 150 mL/hr until desired blood pressure reduction is achieved. ( 2.1 ) If unacceptable hypotension or tachycardia occurs, discontinue the infusion. When blood pressure and heart rate stabilize, restart the infusion at low doses such as 30 to 50 mL/hr. ( 2.2 )",
    "warningsAndPrecautions": null,
    "adverseReactions": "Do not use in patients with advanced aortic stenosis ( 4.1 )."
}